ADL Pharma SRL
ADL Pharma reported total assets of 554,031 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of ADL Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ADL Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
ADL Pharma's financial analysis
- Solvency8.2%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ADL Pharma
ADL Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1004.847.744
- VAT number
- BE1004847744
- Peppol
- Registered · 0208:1004847744 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jan 2024
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
ADL Pharma (SRL) has been based in Leuven since 2024, active in: activities of holding companies. For 2025, it reports a net profit of 31,011 € and equity of 45,664 €; its revenue is not published. Its solvency stands at 8.2%, below the median of its sector (55.6%).
Companies similar to ADL Pharma
Companies in the same business, of comparable size and area, outside its group.
- Swaver Activities of holding companies Nijlen · balance sheet 368,354 €
- Sedes Activities of holding companies Kalmthout · balance sheet 17,961 €
- Derycon Activities of holding companies Knokke-Heist · balance sheet 134,483 €
- International Defence System Support Activities of holding companies Bredene · balance sheet 3,156 €
- KOFFIEGOED België Activities of holding companies Brasschaat · balance sheet 115,342 €
- Artef Activities of holding companies Brasschaat · balance sheet 751 €
- SKS Holding Activities of holding companies Brasschaat · balance sheet 23,272 €
- Aegiris Activities of holding companies Sint-Martens-Latem · balance sheet 555,091 €
Frequently asked questions about ADL Pharma
What is the revenue of ADL Pharma?
ADL Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ADL Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1004847744 for ADL Pharma, if the company is VAT-registered. Its company number (CBE) is 1004.847.744.
Where is the registered office of ADL Pharma?
According to the CBE register, the registered office of ADL Pharma is in 3001 Leuven.
What is the equity of ADL Pharma?
At the close of the 2025 financial year, the equity of ADL Pharma amounts to 45,664 €, a solvency of 8.2% of total assets.
Who manages ADL Pharma?
The register lists 1 active mandates at ADL Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ADL Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →